Table 1.
Overview of HBM4EU-aligned studies and data sources based on bilateral agreements performing biomonitoring acrylamide metabolites, performed between 2014 and 2017 in teenagers and children.
| Provider of Data | Study Label | Data Code | Year of Sampling | Number of Participants (Non-Smoker) | Mean Age (Years) | Age Range |
|---|---|---|---|---|---|---|
| EPIUD | NAC II | IT1 | 2014 | 18 | 7.0 | 7 |
| EPIUD | NAC II | IT2 | 2015 | 132 | 7.2 | 7–8 |
| EPIUD | NAC II | IT3 | 2016 | 147 | 7.0 | 7 |
| UBA | GerES V | DE1 | 2015 | 852 | 10.3 | 3–18 |
| UBA | GerES V | DE2 | 2016 | 849 | 10.3 | 3–18 |
| UBA | GerES V | DE3 | 2017 | 517 | 10.3 | 3–18 |
| NIPH | NEB II | NO | 2016 | 289 | 9.8 | 7–11 |
| ANSP | ESTEBAN | FR1c | 2014 | 55 | 8.5 | 6–11 |
| ANSP | ESTEBAN | FR2c | 2015 | 208 | 8.9 | 6–11 |
| ANSP | ESTEBAN | FR3c | 2016 | 37 | 8.9 | 6–11 |